About Enzalutamide
            
            Class: | Androgen receptor inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and metastatic hormone-sensitive prostate cancer (mHSPC)  
Adult dose: | 160 mg orally once daily (four 40 mg capsules)  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Fatigue, hot flashes, hypertension, diarrhea, nausea, arthralgia, and seizures  
Contraindications: | Hype
         
        
            
                
                
                    
                        Drug Class
                    
                    Androgen receptor inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and metastatic hormone-sensitive prostate cancer (mHSPC)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Astellas Pharma Europe B.V., NETHERLANDS
                    
                    
                    Package Size
                    112's (28's Wallet x 4)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 19511.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        160 mg orally once daily (four 40 mg capsules)
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, hot flashes, hypertension, diarrhea, nausea, arthralgia, and seizures
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to enzalutamide or any component of the formulation; pregnancy and breastfeeding
         
        
        
            
                Important Warnings
            
            Risk of seizures; monitor for signs of seizures; may cause hypertension; potential for drug interactions; not recommended for use in women due to potential harm to a fetus or nursing infant
         
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Androgen receptor inhibitor medicines available in UAE pharmacies
            
            
            
                Darolutamide
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.